Cookies on this website
We use cookies to ensure that we give you the best experience on our website. If you click 'Continue' we'll assume that you are happy to receive all cookies and you won't see this message again. Click 'Find out more' for information on how to change your cookie settings.

Scientists from two departments within University of Oxford Medical Sciences Division have been awarded research grants by the British Medical Association.

Dr Lynda Coughlan (left) and Dr Jeremy Howick (right) receiving their awards
Dr Lynda Coughlan (left), BMA President, Professor Pali Hungin (centre) and Dr Jeremy Howick (right)

Dr Jeremy Howick and Prof Paul Nicholas Aveyard from Nuffield Department of Primary Care Health Sciences were awarded the Dawkins & Strutt grant of almost £60,000 to support pioneering research into pain treatment. The HC Roscoe grant of £50,000 was awarded to Jenner Institute scientists from Nuffield Department of Medicine, Dr Lynda Coughlan and Prof Adrian Hill, who will use the funding to develop improved vaccines for influenza and other emerging infectious diseases.

The work of the BMA Foundation continues to be a success, and each year we fund important, innovative projects to advance medical research. With research funding budgets constrained, we want to support and encourage the medical profession in pursuing high-quality research projects that deliver important improvements in patient care. - Dr Mark Porter, BMA council chair and chair of the foundation trustees commenting on the awards

Fifteen medical academics and research scientists were awarded a total of £500,000 at this year’s prestigious BMA Foundation for Medical Research Awards on Tuesday 22 November. The awards were presented by BMA President, Professor Pali Hungin.

The BMA was one of the first professional bodies to award grants and prizes, with the aim of encouraging and furthering medical research. These grants fund basic and clinical medical research, covering a diverse range of research areas including pain treatment, viral infection and cancer. The BMA Foundation for Medical Research Awards has had a significant impact on the professional development of grant winners, with 96 per cent of previous winning researchers saying that being awarded the grant contributed to their future research. 

Commenting on her award, Dr Coughlan said: “As an early-career researcher starting to establish independence, this grant will have a huge impact on my future careerExosomes are a new and exciting breakthrough in health-innovation and we hope that support of this research will lead to the development of improved vaccines for infectious disease in the near future”.

Dr. Howick commented: “This award will generate the evidence base required for a research programme that promises to tackle the growing problem with too much medicine in the growing ageing population that suffers from pain

Links

Similar stories

PRINCIPLE Covid-19 treatments trial widens to under 50s and adds colchicine

Clinical Trials Coronavirus COVID-19 General Research

From today, the UK’s national priority platform trial of Covid-19 treatments for recovery at home launches its investigation of the gout drug colchicine, and expands for the first time to include adults of any age.

Singula Bio, a new Oxford spin-out company - Cancer need not be fatal

General Innovation Research

Singula Bio, a bold new seed-stage biotechnology company spun out of Oxford University, has been launched with the intention of helping show that cancer need not be fatal. Led by three Oxford cancer specialists, the firm is aims to become a world leader in therapies to use against difficult-to-treat solid malignancies such as ovarian cancer - using the body’s own immune system to fight previously fatal cancers.

Major rise in public support for COVID vaccine – Oxford study

Coronavirus COVID-19 General Research

More than three quarters of people in the UK now say they are ’very likely’ to have the vaccine – up from 50% among the same group of survey respondents five months ago –according to a two-wave Oxford University survey published today.

Coronavirus vaccination linked to substantial reduction in hospitalisation, real-world data suggests

Coronavirus COVID-19 General Research

The first study to describe the effects in real-world communities of the Oxford coronavirus vaccine has been reported in a pre-print publication today, showing a clear reduction in the risk of hospitalisation from COVID-19 amongst those who have received the vaccine.

World’s largest clinical trial for COVID-19 treatments expands internationally

Clinical Trials Coronavirus COVID-19 General

The Randomised Evaluation of COVID-19 Therapy (RECOVERY) Trial, the world’s largest clinical trial for COVID-19 treatments, has now expanded internationally with Indonesia and Nepal among the first countries to join. The first patients have been recruited to RECOVERY International.